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Abstract
Background: Selection of patients with local failure of nasopharyngeal carcinoma (NPC) for
appropriate type of salvage treatment can be difficult due to the lack of data on comparative efficacy
of different salvage treatments. The purpose of the present study was to validate a previously
published prognostic scoring system for local failures of NPC treated by radiosurgery based on
reported results in the literature.
Methods: A literature search yielded 3 published reports on the use of radiosurgery as salvage
treatment of NPC that contained sufficient clinical information for validation of the scoring system.
Prognostic scores of 18 patients from these reports were calculated and actuarial survival rates
were estimated and compared to the original cohort used to design the prognostic scoring system.
The area under the receiver operating characteristic curve was also determined and compared
between the current and original patient groups.
Results: The calculated prognostic scores ranged from 0.32 to 1.21, with 15 patients assigned to
the poor prognostic group and 3 to the intermediate prognostic group. The actuarial 3-year
survival rates in the intermediate and poor prognostic groups were 67% and 0%, respectively.
These results were comparable to the observed 3-year survival rates of 74% and 23% in the
intermediate and poor prognostic group in the original reports. The area under the receiver
operating characteristic curve for the current patient group was 0.846 which was similar to 0.841
in the original group.
Conclusion: The previously published prognostic scoring system demonstrated good prediction
of treatment outcome after radiosurgery in a small group of NPC patients with poor prognosis.
Prospective study to validate the scoring system is currently being carried out in our institution.
Background
Loco-regional control rate of nasopharyngeal carcinoma
(NPC) has improved significantly in the past decade due
to the advances in imaging, radiotherapy technique, and
the use of combined modality treatment. The reported 5-
year local control rates of NPC in modern series ranged
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from 81 to 85%, with control rates exceeding 90% for
patients with T1 disease [1,2]. Despite the improved out-
come in local control, local recurrence still represents a
major cause of mortality and morbidity in advanced stage
disease, and management of local failure remains an
important and challenging issue in NPC.
Aggressive salvage treatment is generally recommended
for local recurrence since long-term control can still be
achieved in some patients. When the recurrent tumor is
confined to the nasopharynx, both nasopharyngectomy
and brachytherapy can be used with a long term control
rate of 52–72% [3-5]. Patients with more extensive or
bulky disease however often required external beam re-
irradiation, but treatment outcome with conventional
radiotherapy was unsatisfactory with a poor survival rate
and a high incidence of late complication [6,7]. The use of
intensity-modulated radiotherapy (IMRT) in retreatment
of NPC allows better sparing of normal tissues while
delivering high dose to the target, and preliminary reports
using IMRT for re-irradiation of NPC showed good short-
term control with a relatively low incidence of severe tox-
icities [8]. Stereotactic radiotherapy has also been
employed in the treatment of local failures of NPC, with
long term control rates of 53 to 86% [9-12]. Compared to
other salvage treatments, stereotactic radiotherapy has the
advantage of being applicable to deep-seated tumor such
as recurrence in the skull base or intracranium. Stereotac-
tic radiotherapy also allows better sparing of critical struc-
tures that are in close vicinity to the target. No direct
comparison of different salvage treatment techniques for
NPC has ever been reported, and the choice of treatment
largely depends on the tumor extent, available expertise,
and patient/clinician preference. On the other hand, it is
important to identify prognostic factors that may predict
good or poor outcome using specific salvage treatment
and use them clinically to select patient for appropriate
type of salvage treatment. A prognostic scoring system for
locally recurrent NPC treated by stereotactic radiosurgery
was reported by us previously [13]. In order to validate the
scoring system, we collected relevant data from published
literature on the use of radiosurgery for local failures of
NPC and compared the performance of the prognostic
scoring system in this patient group with the original one
used to design the scoring system.
Methods
Prognostic factors of a cohort of 48 patients with local fail-
ure of NPC treated by stereotactic radiosurgery in our
institution were identified and a prognostic scoring was
then designed to predict treatment outcome. All these
patients were treated by stereotactic radiosurgery using a
modified linear accelerator and a median dose of 12.5 Gy
(range: 12 to 18 Gy) was delivered to the target. Briefly, 5
factors were included in the scoring system: age, recurrent/
persistent disease, recurrent T (rT) stage, tumor volume,
and previous salvage treatment. In staging the recurrent
tumor, the same 1997 American Joint Committee on Can-
cer stage classification system [14] used for staging of pri-
mary tumor in newly diagnosed NPC was adopted: T1 if
tumor is localized in nasopharynx, T2 if tumor has extend
to nasal fossa, parapharyngeal space or oropharynx, T3 if
there is evidence of skull base or other para-nasal sinus
involvement, and T4 if there is extension into intracra-
nium, orbit, hypopharynx or cranial nerve involvement.
The relative risks associated with these factors were repre-
sented by the estimated risk coefficient obtained by the
Cox proportional hazards regression model and the value
ranged from 0.05 to 0.39. A score of 0 was assigned if the
adverse factor was not present, or a value equal to the esti-
mated risk coefficient if the factor was present. The relative
risk of failure after radiosurgery for each patient (prognos-
tic score) was then estimated by summing the relative risk
of individual factors. Patients were then grouped to the
following subgroups based on the calculated prognostic
score: good prognostic group with a score of 0, intermedi-
ate prognostic group with a score > 0 to 0.5, and poor
prognostic group with a score > 0.5. 5-year local relapse-
free rates in the good, intermediate and poor prognostic
groups were 100%, 42.5% and 9.6%, respectively. The
corresponding 5-year survival rates were 100%, 51.1%
and 0%.
Validation of the scoring system was performed using
published data from the literature. A literature search was
performed in Pubmed http://www.pubmed.com using
the words "nasopharyngeal carcinoma" and "radiosur-
gery". Only published papers using radiosurgery for treat-
ment of persistent and recurrent nasopharyngeal
carcinoma were considered, and papers on the use of radi-
osurgery as a boost treatment following primary radio-
therapy were excluded. Papers containing sufficient
information on patient and disease characteristics for cal-
culation of scoring system were then included in this
study. Prognostic scoring system of individual patient was
calculated and actuarial tumor control and/or survival
rates in different prognostic groups were then estimated
and compared with our published results. The perform-
ance of the scoring system was also further examined com-
paring the area under the receiver operating characteristic
(ROC) curve in the current and original patient groups.
Results
A search in Pubmed using the specified keywords yielded
34 publications. Of these, 8 were reported by us and these
were excluded from the validation study. The remaining
26 papers were carefully reviewed for inclusion into the
study, and only 3 papers contained sufficient data on indi-
vidual patient and disease characteristics for the purpose
of estimation of prognostic scores. The prognostic score ofBMC Cancer 2009, 9:131 http://www.biomedcentral.com/1471-2407/9/131
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individual patient was calculated based on the available
information in the published manuscripts (Table 1). In
case the prognostic score could not be calculated due to
missing information, the mean score was obtained by esti-
mating the lowest and highest score for that patient. The
first paper by Chen et al [15] included 11 patients with rT4
disease with radiosurgery given to tumor extended to skull
base and intracranium. In Chen's series, radiosurgery was
performed using a modified linear accelerator, and a
median dose of 14 Gy (range: 10 to 15 Gy) was delivered
to the target. The calculated prognostic scores in Chen's
series ranged from 0.32 to 0.8 with 10 patients classified
as poor prognostic group and 1 patient as intermediate
prognostic group. In the second paper by O'Donnell et al
[16], two patients received radiosurgery using Gamma
Knife (Elekta, Sweden) with a dose of 14 Gy, and both
were classified as intermediate prognostic group. In the
third paper by Kocher et al [17], 5 patients received radio-
surgery using modified linear accelerator with a median
dose of 20 Gy (range: 15 to 24 Gy) for local failure of
nasopharyngeal carcinoma, and the calculated scores
ranged from 0.75 to 1.21 thus all 5 patients were classified
as poor prognostic group.
Data of all these patients were pooled together according
to their prognostic group for comparison. Only overall
survival rate was analyzed since local control status was
not clearly defined as an endpoint in most patients. In the
current cohort, the actuarial 3-year survival rates in the
intermediate and poor prognostic groups were 67% and
0%, respectively. These results were comparable to the
observed 3-year survival rate of 74% in the intermediate
prognostic group and 31% in the poor prognostic group
as described in our original report. Figure 1 shows the sur-
vival curves according to prognostic groups in the current
and original cohorts. Although none of the patients in the
current cohort belonged to the good prognostic group and
there were few in the intermediate prognostic group, the
survival curve of those assigned to the poor prognostic
group was similar in both cohorts, suggesting that the
scoring system is at least useful in predicting poor out-
come in poor prognostic group after radiosurgery. To fur-
ther assess the performance of the prognostic scoring
system, the area under the ROC curve was calculated. If
the performance of the scoring system resembles flipping
a coin in predicting treatment outcome, the area under the
ROC curve is close to 0.5. If the area is 1.0, then the model
has 100% sensitivity and specificity in predicting outcome
regardless of cut-off point. Figure 2 shows the ROC curves
for overall survival for the current cohort and the original
cohort used to design the scoring system. The calculated
area under the ROC curve for the current cohort was 0.846
(95% C.I.: 0.66, 1.03) which is comparable to 0.841 (95%
C.I.: 0.731, 0.952) in the original cohort, suggesting good
predictive performance using the scoring system.
Discussion
Treatment of local recurrence of NPC is usually recom-
mended since a proportion of patients with local failure
can still be successfully salvaged. In a retrospective review
of 319 patients with isolated local failure of NPC, patients
who received salvage treatment had a significantly better
survival rate than those without salvage treatment, and
patient who received surgery or re-irradiation had a better
Table 1: Prognostic factors and calculated score of patients included in the current validation study
Patient Age/score rT stage/score Persistent vs recurrent 
disease/score
Tumor volume (cc)/
score
Prior salvage/score Prognostic score Prognostic group
1 53/1 rT4/1 Recurrent/1 0.91/0 NR 0.74 Poor
2 35/0 rT4/1 Recurrent/1 0.66/0 NR 0.52 poor
3 44/0 rT4/1 Recurrent/1 5.77/0 Yes/1 0.71 Poor
4 44/0 rT4/1 Recurrent/1 13.81/1 NR 0.8 Poor
5 55/1 rT4/1 Recurrent/1 1.31/0 NR 0.74 Poor
6 39/0 rT4/1 Recurrent/1 8.51/0 No/0 0.32 Intermediate
7 44/0 rT4/1 Recurrent/1 7.91/0 NR 0.52 poor
8 70/1 rT4/1 Recurrent/1 2.85/0 NR 0.74 Poor
9 63/1 rT4/1 Recurrent/1 15.77/1 NR 0.74 Poor
10 47/1 rT4/1 Recurrent/1 6.43/0 NR 0.74 Poor
11 38/0 rT4/1 Recurrent/1 13.03/1 NR 0.8 Poor
12 51/1 rT4/0 Recurrent/1 3.3/0 No/0 0.49 Intermediate
13 69/1 rT4/0 Recurrent/1 <10/0 No/0 0.49 Intermediate
14 58/1 rT4/1 Recurrent/1 8/0 Yes/1 0.93 Poor
15 47/1 rT4/1 NR 33/1 No/0 0.75 Poor
16 60/1 rT4/1 NR 60/1 No/0 0.75 Poor
17 61/1 rT4/1 Recurrent/1 22/1 Yes/1 1.21 Poor
18 51/1 rT4/1 Recurrent/1 52/1 Yes/1 1.21 Poor
NR: Not reportedBMC Cancer 2009, 9:131 http://www.biomedcentral.com/1471-2407/9/131
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survival rate than those treated by chemotherapy alone
[18]. Several salvage treatments including nasopharyngec-
tomy, brachytherapy and external beam re-irradiation are
commonly employed for local failure of NPC, and the
choice of treatment is largely determined by the extent
and site of recurrence as well as available expertise. For
patient with recurrent disease that is amenable to more
than one treatment option, few reports are available to
address the relative efficacy of different types of salvage
treatment [19], and the decision is largely a matter of
patient and/or clinician preference. Since prospective ran-
domized trial to compare different treatments in salvaging
local failure is difficult to conduct due to the falling inci-
dence of recurrence and the highly specialized nature of
different salvage treatments, it is important to review
prognostic factor in order to identify patients that are
likely to benefit from specific type of salvage treatment.
Our previously published prognostic scoring system is a
simple and objective way to assess possible benefits of
radiosurgery for local failures of NPC.
The prognostic factors included in the scoring system have
also been identified in patients with recurrent NPC treated
by surgery, brachytherapy and/or external beam re-irradi-
ation. Most series also reported T stage and time to recur-
rence as significant prognostic factors for local control
and/or survival [6,7,20,21]. The most consistent prognos-
tic factor being reported was rT stage, and patients treated
for advanced T stage generally suffered from poor tumor
control and short survival time. Despite these similarities
in prognostic factors, our scoring system cannot be
applied directly to patients using salvage treatments other
than radiosurgery, since the system is optimally modeled
to the original data based on a group of patients with dis-
Comparison of survival curves according to prognostic groups from original patient group (solid line) and the current patient  group (dashed line) Figure 1
Comparison of survival curves according to prognostic groups from original patient group (solid line) and the 
current patient group (dashed line). For current patient group, only the poor prognostic group was shown due to 
absence or small number of patients in other prognostic groups.BMC Cancer 2009, 9:131 http://www.biomedcentral.com/1471-2407/9/131
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Receiver operating characteristic curve for predicting overall survival after radiosurgery using prognostic scoring system in cur- rent patient group (top) and original patient group (bottom) Figure 2
Receiver operating characteristic curve for predicting overall survival after radiosurgery using prognostic scor-
ing system in current patient group (top) and original patient group (bottom).BMC Cancer 2009, 9:131 http://www.biomedcentral.com/1471-2407/9/131
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ease that were technically feasible for radiosurgery. Thus
the weighting for rT4 disease is relatively small in the scor-
ing system since majority of our patients did not have rT4
disease. In clinical practice, rT4 is an important poor prog-
nostic factor and likely to carry a heavier weighting in
patients treated by other means.
There are two major limitations of the current patient data
set that we used to validate our scoring system. One limi-
tation is the relatively small number of patients due to the
lack of individual patient data available from most pub-
lished reports. The other limitation is over-representation
of patients in the poor prognostic group, reflecting the
selection of those with relatively poor prognosis for radi-
osurgery in the literature, thereby limiting the validation
of the scoring system to this particular prognostic group
only. We are currently applying the prognostic scoring sys-
tem in our institution to select patients with local failures
of NPC for radiosurgery. This prospective exercise will
provide additional data useful for validation in patients
with good and intermediate prognostic groups since these
are the patients likely to be selected for radiosurgery.
Conclusion
The previously published prognostic scoring system dem-
onstrated good prediction of treatment outcome after
radiosurgery in a small group of NPC patients with poor
prognosis. Prospective study to validate the scoring sys-
tem is currently being carried out in our institution.
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